Zinc oxide nanoparticles and monocytes: Impact of size, charge and solubility on activation status

Toxicology and Applied Pharmacology

Volumn 266, Issue 1, 2013, Pages 19-26

  Prach, Morag ^a   Stone, Vicki ^b   Proudfoot, Lorna ^a  

^a EDINBURGH NAPIER UNIVERSITY   (United Kingdom)

^b HERIOT WATT UNIVERSITY   (United Kingdom)

Author keywords

Cytotoxicity; Monocytes; Nanoparticles; Zinc oxide

Indexed keywords

CD11B ANTIGEN; CD14 ANTIGEN; HLA DR ANTIGEN; NANOPARTICLE; TUMOR NECROSIS FACTOR ALPHA; ZINC ION; ZINC OXIDE;

ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CELL ACTIVATION; CELL VIABILITY; CENTRIFUGATION; CONTROLLED STUDY; CYTOTOXICITY; DISSOLUTION; EXPOSURE; FILTRATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MONOCYTE; SOLUBILITY;

HUMANS; MONOCYTES; NANOPARTICLES; PARTICLE SIZE; SOLUBILITY; ZINC OXIDE;

BOVINAE;

EID: 84869863159     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2012.10.020     Document Type: Article

References (47)

1. Applerot G., Lipovsky A., Dror R., Perkas N., Nitzan Y., Lubart R., Gedanken A. Enhanced antibacterial activity of nanocrystalline ZnO due to increased ROS-mediated cell injury. Adv. Funct. Mater. 2009, 19:842-852.
2. Asati A., Santra S., Kaittanis C., Perez J.M. Surface-charge-dependent cell localization and cytotoxicity of cerium oxide nanoparticles. ACS Nano 2010, 4:5321-5331.
3. Bao B., Prasad A.S., Beck F.W.J., Godmere M. Zinc modulates mRNA levels of cytokines. Am. J. Physiol. Endocrinol. Metab. 2003, 285:E1095-E1102.
4. Berridge M.V., Tan A.S., McCoy K.D., Wang R. The biochemical and cellular basis of cell proliferation assays that use tetrazolium salts. Biochemica 1996, 4:14-19.
5. Brown D.M., Dickson C., Duncan P., Al-Attili F., Stone V. Interaction between nanoparticles and cytokine proteins: impact on protein and particle functionality. Nanotechnology 2010, 21:215104.
6. Brunner T.J., Wick P., Manser P., Spohn P., Grass R.N., Limbach L.K., Bruinink A., Stark W. In vitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica and the effect of particle solubility. Environ. Sci. Technol. 2006, 40:4374-4381.
7. Castet D., Bouillard J. Acute pneumopathy caused by exposure to zinc oxide. Rev. Mal. Respir. 1992, 9:632-633.
8. Cho W.-S., Duffin R., Poland C.A., Howie S.E.M., MacNee W., Bradley M., Megson I.L., Donaldson K. Metal oxide nanoparticles induce unique inflammatory footprints in the lung: important implications for nanoparticle testing. Environ. Health Perspect. 2010, 118(12):1699-1706.
9. 2+ dissolution inside lysosomes. Part. Fibre Toxicol. 2011, 8:27-42.
10. Cho W.-S., Duffin R., Poland C.A., Duschl A., Oostingh G.J., MacNee W., Bradley M., Megson I.L., Donaldson K. Differential pro-inflammatory effects of metal oxide nanoparticles and their soluble ions in vitro and in vivo; zinc and copper nanoparticles, but not their ions, recruit eosinophils to the lungs. Nanotoxicology 2012, 6:22-35.
11. 2 to a freshwater microalga (Pseudokirchneriella subcapitata): the importance of particle solubility. Environ. Sci. Technol. 2007, 41:8484-8490.
12. Gupta N.K., Sharma V., Dixit V.K. Development and characterization of chitosan coated poly-(ε-caprolacone) nanoparticulate system for effective immunization against influenza. Vaccine 2011, 29:9026-9037.
13. Hanley C., Thurber A., Hanna C., Punnoose A., Zhang J., Wingett D.G. The influences of cell type and ZnO nanoparticle size on immune cell cytotoxicity and cytokine induction. Nanoscale Res. Lett. 2009, 4:1409-1420.
14. 2 to bacteria Vibrio fischeri and crustaceans Daphnia magna and Thamnocephalus platyurus. Chemosphere 2008, 71:1308-1316.
15. Hong H., Shi J., Yang Y., Zhang Y., Engle J.W., Nickles R.J., Wang X., Cai W. Cancer-targeted optical imaging with fluorescent zinc oxide nanowires. Nano Lett. 2011, 11:3744-3750.
16. Horie M., Nishio K., Fujita K., Endoh S., Miyauchi A., Saito Y., Iwahashi H., Yamamoto K., Murayama H., Nakano H., Nanashima N., Niki E., Yoshida Y. Protein adsorption of ultrafine metal oxide and its influence on cytotoxicity toward cultured cells. Chem. Res. Toxicol. 2009, 22:543-553.
17. Huang C.C., Aronstam R.S., Chen D.R., Huang Y.W. Oxidative stress, calcium homeostasis, and altered gene expression in human lung epithelial cells exposed to ZnO nanoparticles. Toxicol. In Vitro 2010, 24:45-55.
18. Kao Y.-Y., Chen Y.-C., Cheng T.-J., Chiung Y.-M., Liu P.-S. Zinc oxide nanoparticles interfere with zinc ion homeostasis to cause cytotoxicity. Toxicol. Sci. 2012, 125:462-472.
19. Karlsson H.L., Cronholm P., Gustafsson J., Moller L. Copper oxide nanoparticles are highly toxic: a comparison between metal oxide nanoparticles and carbon nanotubes. Chem. Res. Toxicol. 2008, 21:1726-1732.
20. Kitamura H., Morikawa H., Kamon H., Iguchi M., Hojyo S., Fukada T., Yamashita S., Kaisho T., Akira S., Murakami M., Hirano T. Toll-like receptor-mediated regulation of zinc homeostasis influences dendritic cell function. Nat. Immunol. 2006, 7:971-977.
21. Knoell D.L., Liu M.-J. Impact of zinc metabolism on innate immune function in the setting of sepsis. Int. Z. Vitam. Ernahrungsforsch. Beih. 2010, 80:271-277.
22. Limbach L.K., Wick P., Manser P., Grass R.N., Bruinink A., Stark W.J. Exposure of engineered nanoparticles to human lung epithelial cells: influence of chemical composition and catalytic activity on oxidative stress. Environ. Sci. Technol. 2007, 41:4158-4163.
23. Maret W. New perspectives of zinc coordination environments in proteins. J. Inorg. Biochem. 2012, 111:110-116.
24. Meerarani P., Ramadass P., Toborek M., Bauer H.-C., Bauer H., Hennig B. Zinc protects against apoptosis of endothelial cells induced by linoleic acid and tumor necrosis factor α. Am. J. Clin. Nutr. 2000, 71:81-87.
25. Moos P.J., Chung K., Woessner D., Honeggar M., Cutler S., Veranth J.M. ZnO particulate matter requires cell contact for toxicity in human colon cancer cells. Chem. Res. Toxicol. 2010, 23:733-739.
26. Moos P.J., Olszewski K., Honeggar M., Cassidy P., Leachman S., Woessner D., Cutler N.S., Veranth J.M. Responses of human cells to ZnO nanoparticles: a gene transcription study. Metallomics 2011, 3:1199-1211.
27. Nag N., Bhattacharya A., Gupta R.K., Manivannan K., Kahol P.K., Wanekaya A.K., Delong R.K., Ghosh K. Glucose stabilized ZnO nanoparticles for biomedical applications. J. Nanosci. Lett. 2011, 1:172-178.
28. 2+ differentially?. Nanotoxicology 2012, 6(4):371-380.
29. Nemmar A., Hoylaerts M.F., Hoet P.H.M., Vermylen J., Nemery B. Size effect of intratracheally instilled particles on pulmonary inflammation and vascular thrombosis. Toxicol. Appl. Pharmacol. 2003, 186:38-45.
30. Osmond M.J., McCall M.J. Zinc oxide nanoparticles in modern sunscreens: an analysis of potential exposure and hazard. Nanotoxicology 2010, 4:15-41.
31. Perrie Y., Frederik P.M., Gregoriadis G. Liposome-mediated DNA vaccination: the effect of vesicle composition. Vaccine 2001, 19:3301-3310.
32. Plum L.M., Rink L., Haase H. The essential toxin: impact of zinc on human health. Int. J. Environ. Res. Public Health 2010, 7:1342-1365.
33. Rasmussen J.W., Martinez E., Louka P., Wingett D.G. Zinc oxide nanoparticles for selective destruction of tumor cells and potential for drug delivery applications. Expert Opin. Drug Deliv. 2010, 7:1063-1077.
34. Rink L., Gabriel P. Zinc and the immune system. Proc. Nutr. Soc. 2000, 59:541-552.
35. Roiter Y., Ornatska M., Rammohan A.R., Balakrishnan J., Heine D.R., Minko S. Interaction of nanoparticles with lipid membrane. Nano Lett. 2008, 8:941-944.
36. Slowing I.I., Wu C.-W., Vivero-Escoto J.L., Lin V.S.-Y. Mesoporous silica nanoparticles for reducing hemolytic activity towards mammalian red blood cells. Small 2009, 5:57-62.
37. Springer T.A. Adhesion receptors of the immune system. Nature 1990, 346:425-434.
38. Studer A.M., Limbach L.K., Duc L.V., Krumeich F., Athanassiou E.K., Gerber L.C., Moch H., Stark W.J. Nanoparticle cytotoxicity depends on intracellular solubility: comparison of stabilized copper metal and degradable copper oxide nanoparticles. Toxicol. Lett. 2010, 197:169-174.
39. Takeda K., Kaisho T., Akira S. Toll-like receptors. Annu. Rev. Immunol. 2003, 21:335-376.
40. Tamai R., Sugawara S., Takeuchi O., Akira S., Takada H. Synergistic effects of lipopolysaccharide and interferon-γ in inducing interleukin-8 production in human monocytic THP-1 cells is accompanied by up-regulation of CD14, Toll-like receptor 4, MD-2 and MyD88 expression. J. Endotoxin Res. 2003, 9:145-153.
41. Tsuchiya S., Yamabe M., Yamaguchi Y., Kobayashi Y., Konno T., Tada K. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int. J. Cancer 1980, 26:171-176.
42. Watjen W., Haase H., Biagioli M., Beyersmann D. Induction of apoptosis in mammalian cells by cadmium and zinc. Environ. Health Perspect. 2002, 110(S5):865-867.
43. Xia T., Kovochich M., Brant J., Hotze M., Sempf J., Oberley T., Sioutas C., Yeh J.I., Wiesner M.R., Nel A.E. Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett. 2006, 6:1794-1807.
44. Xia T., Kovochich M., Liong M., Madler L., Gilbert B., Shi H., Yeh J.I., Zink J.I., Nel A.E. Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS Nano 2008, 2:2121-2134.
45. 2+ release from zinc and zinc oxide particles in simulated uterine solution. Colloids Surf. B Biointerfaces 2006, 47:140-145.
46. Yazdanbakhsh M., Kremsner P.G., Ree R. Allergy, parasites and the hygiene hypothesis. Science 2002, 296:490-494.
47. Zhang H., Xia T., Meng H., Xue M., George S., Ji Z., Wang X., Liu R., Wang M., France B., Rallo R., Damoiseaux R., Cohen Y., Bradley K.A., Zink J.I., Nel A.E. Differential expression of syndecan-1 mediates cationic nanoparticle toxicity in undifferentiated versus differentiated normal human bronchial epithelial cells. ACS Nano 2011, 5:2756-2769.